Clinical Characteristics and Disease Progression in Early-Stage COVID-19 Patients in South Korea
et al., Journal of Clinical Medicine,
Retrospective 293 patients in South Korea, showing higher risk of progression with metformin use, without statistical significance.
risk of progression, 120.0% higher, OR 2.20, p = 0.26, treatment 6 of 36 (16.7%) cases,
3 of 36 (8.3%) controls, case control OR, propensity score matching.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Choi et al., 23 Jun 2020, retrospective, South Korea, peer-reviewed, median age 29.0, 8 authors, study period 5 March, 2020 - 18 March, 2020.
firstname.lastname@example.org (corresponding author), email@example.com, firstname.lastname@example.org, email@example.com, firstname.lastname@example.org, email@example.com, firstname.lastname@example.org, email@example.com.